CBD Life Sciences (OTCMKTS: CBDL), via its wholly owned subsidiary LBC Bioscience Inc., announced on August 18, 2022, about introducing a product that is infused with both Delta-8 & Delta-9. These yummy, apple-flavored gummies contain 15MG of Delta-8 & 10MG of Delta-9 per gummy and will come in a 15-Count Jar.
Trading Data
On Thursday, CBDL stock ended flat at $0.0002 with more than 78.84 million shares, compared to its average volume of 49.13 million shares. The stock moved within a range of $0.0001 – 0.0002 after opening trade at $0.0002.
Delta-8-THC induces a mild psychoactive high, making it popular for recreational use and potential for therapeutic use. The product is perfect for soothing the mind while helping to stay focused all the time. It will soon be available in stores, and also on the LBC Bioscience website. All products are carefully blended to ensure consistency along with Third Party Lab Testing for verification.
On July 14, 2022, the company launched its own Delta-8 infused snacks. They come in five different kinds of bags and are packed with 500MG of pure Delta-8. Flavors available are Cheetos, Dank Funions, Doritos, Oreos, & Trips Ahoy.
President and CEO Lisa Nelson, says that they have been working hard to experiment and come up with new products for consumers and shareholders, The company sources the best Delta-8 distillate, after which they take the cleanest terpenes and infuse them to create these amazing products. The result is there for all to see!
Key Quote
President & CEO Lisa Nelson states, “We are always trying to surpass the competition with little amounts of extra ingredients we use. Sourcing only the best Delta-8 distillate we then take the cleanest terpenes and infuse them to bring you these products that will not disappoint!” Lisa Nelson also stated, “This product will be a perfect sleep aid for consumers, and it is a powerful addition to our stacked inventory!” Delta-8 THC is taking over the CBD marketplace and CBD Life Sciences Inc. has exactly what people are looking for!
Technical Data
CBDL stock is trading below the 20-Day and 50-Day Moving averages of $0.0002 and $0.0002 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0002. The company has a total market capitalization of $4.81 million. The stock is up 5% over the past month.
